I remember hearing in the early 1990s that some people had a natural resistance 
to AIDS. They would get the HIV virus. It would be detectable. But even without 
treatment, they never acquired full-blown AIDS. 




On Jul 10, 2010, at 1:38 AM, "Mr. Worf" <[email protected]> wrote:

> That would make sense that some folks in Africa would have a natural immunity 
> to it. Like folks in Europe that are naturally immune to the black plague. 
> 
> 
> On Fri, Jul 9, 2010 at 4:23 PM, Kelwyn <[email protected]> wrote:
> I saw this in the Wall Street Journal (and posted it practically everywhere 
> but here).  The HIV antibodies were discovered in the cells of a 60-year-old 
> African-American gay man, known in the scientific literature as Donor 45, 
> whose body made the antibodies naturally.  That is absolutely wild to me!
> 
> ~rave!
> 
> --- In [email protected], "Mr. Worf" <hellomahog...@...> wrote:
> >
> > Scientists discover antibodies that neutralize over 91 percent of HIV
> > strains
> >
> > By Darren Quick <http://www.gizmag.com/author/darren-quick/>
> >
> > *19:58 July 8, 2010*
> >
> > 1 
> > Picture<http://www.gizmag.com/antibodies-neutralize-over-90-percent-of-hiv-strains/15662/picture/117491/>
> >   [image: The atomic structure of the antibody VRC01 (blue and green)
> > binding to HIV (grey and red)
> > ...]<http://www.gizmag.com/antibodies-neutralize-over-90-percent-of-hiv-strains/15662/picture/117491/>
> >
> > The atomic structure of the antibody VRC01 (blue and green) binding to HIV
> > (grey and red) (Image: NIAID VRC)
> >   Find an ASO Near
> > You<http://googleads.g.doubleclick.net/aclk?sa=l&ai=BxH1kZow3TMjfF4jSjQTH-a30A-q3m2_mq6r1DcCNtwGg-IkBEAEYASCz3PoBKAQ4AFDj7KDL-v____8BYMmO8IbIo6AZsgEOd3d3Lmdpem1hZy5jb226AQozMDB4MjUwX2pzyAEB2gGlAWh0dHA6Ly93d3cuZ2l6bWFnLmNvbS9hbnRpYm9kaWVzLW5ldXRyYWxpemUtb3Zlci05MC1wZXJjZW50LW9mLWhpdi1zdHJhaW5zLzE1NjYyLz91dG1fc291cmNlPUdpem1hZytTdWJzY3JpYmVycyZ1dG1fY2FtcGFpZ249OTE5MjY5NTRhZC1VQS0yMjM1MzYwLTQmdXRtX21lZGl1bT1lbWFpbMgC1rnhEqgDAegD8QToA7gD6AMt6APvCegD-AT1AwAAAET1AwACAAA&num=1&sig=AGiWqtyp3A5Yq3HMU1O2krjMxJ78-3Y7sA&client=ca-pub-1607124478120364&adurl=http://www.HIVTreatmentIsPower.com%3Fs_kwcid%3DTC%7C6887%7Csupport%2520for%2520hiv%7Cwww.gizmag.com%7CC%7Cb%7C3646087206>-
> > www.HIVTreatmentIsPower.com<http://googleads.g.doubleclick.net/aclk?sa=l&ai=BxH1kZow3TMjfF4jSjQTH-a30A-q3m2_mq6r1DcCNtwGg-IkBEAEYASCz3PoBKAQ4AFDj7KDL-v____8BYMmO8IbIo6AZsgEOd3d3Lmdpem1hZy5jb226AQozMDB4MjUwX2pzyAEB2gGlAWh0dHA6Ly93d3cuZ2l6bWFnLmNvbS9hbnRpYm9kaWVzLW5ldXRyYWxpemUtb3Zlci05MC1wZXJjZW50LW9mLWhpdi1zdHJhaW5zLzE1NjYyLz91dG1fc291cmNlPUdpem1hZytTdWJzY3JpYmVycyZ1dG1fY2FtcGFpZ249OTE5MjY5NTRhZC1VQS0yMjM1MzYwLTQmdXRtX21lZGl1bT1lbWFpbMgC1rnhEqgDAegD8QToA7gD6AMt6APvCegD-AT1AwAAAET1AwACAAA&num=1&sig=AGiWqtyp3A5Yq3HMU1O2krjMxJ78-3Y7sA&client=ca-pub-1607124478120364&adurl=http://www.HIVTreatmentIsPower.com%3Fs_kwcid%3DTC%7C6887%7Csupport%2520for%2520hiv%7Cwww.gizmag.com%7CC%7Cb%7C3646087206>
> > An ASO can provide HIV/AIDS support in many areas. Find one near you.
> > Custom 
> > Antibodies<http://googleads.g.doubleclick.net/aclk?sa=l&ai=BKcOjZow3TMjfF4jSjQTH-a30A-qf3L4Bps7BvA_AjbcB4IObARACGAIgs9z6ASgEOABQrdSd_AZgyY7whsijoBmgAYSA1v4DsgEOd3d3Lmdpem1hZy5jb226AQozMDB4MjUwX2pzyAEB2gGlAWh0dHA6Ly93d3cuZ2l6bWFnLmNvbS9hbnRpYm9kaWVzLW5ldXRyYWxpemUtb3Zlci05MC1wZXJjZW50LW9mLWhpdi1zdHJhaW5zLzE1NjYyLz91dG1fc291cmNlPUdpem1hZytTdWJzY3JpYmVycyZ1dG1fY2FtcGFpZ249OTE5MjY5NTRhZC1VQS0yMjM1MzYwLTQmdXRtX21lZGl1bT1lbWFpbIACAagDAegD8QToA7gD6AMt6APvCegD-AT1AwAAAET1AwACAAA&num=2&sig=AGiWqtxYz4l1x_e9Ssim4Evnu9h-QLeURQ&client=ca-pub-1607124478120364&adurl=http://www.promab.com>-
> > www.promab.com<http://googleads.g.doubleclick.net/aclk?sa=l&ai=BKcOjZow3TMjfF4jSjQTH-a30A-qf3L4Bps7BvA_AjbcB4IObARACGAIgs9z6ASgEOABQrdSd_AZgyY7whsijoBmgAYSA1v4DsgEOd3d3Lmdpem1hZy5jb226AQozMDB4MjUwX2pzyAEB2gGlAWh0dHA6Ly93d3cuZ2l6bWFnLmNvbS9hbnRpYm9kaWVzLW5ldXRyYWxpemUtb3Zlci05MC1wZXJjZW50LW9mLWhpdi1zdHJhaW5zLzE1NjYyLz91dG1fc291cmNlPUdpem1hZytTdWJzY3JpYmVycyZ1dG1fY2FtcGFpZ249OTE5MjY5NTRhZC1VQS0yMjM1MzYwLTQmdXRtX21lZGl1bT1lbWFpbIACAagDAegD8QToA7gD6AMt6APvCegD-AT1AwAAAET1AwACAAA&num=2&sig=AGiWqtxYz4l1x_e9Ssim4Evnu9h-QLeURQ&client=ca-pub-1607124478120364&adurl=http://www.promab.com>
> > High-Quality Research Antibodies. Monoclonals Antibody Service $3,900
> > Vaccine Summit 
> > 2010<http://googleads.g.doubleclick.net/aclk?sa=l&ai=BTv1YZow3TMjfF4jSjQTH-a30A-zVgLMB_O6n4BPAjbcB0PAzEAMYAyCz3PoBKAQ4AFCn39XgBmDJjvCGyKOgGbIBDnd3dy5naXptYWcuY29tugEKMzAweDI1MF9qc8gBAdoBpQFodHRwOi8vd3d3Lmdpem1hZy5jb20vYW50aWJvZGllcy1uZXV0cmFsaXplLW92ZXItOTAtcGVyY2VudC1vZi1oaXYtc3RyYWlucy8xNTY2Mi8_dXRtX3NvdXJjZT1HaXptYWcrU3Vic2NyaWJlcnMmdXRtX2NhbXBhaWduPTkxOTI2OTU0YWQtVUEtMjIzNTM2MC00JnV0bV9tZWRpdW09ZW1haWyAAgGoAwHoA_EE6AO4A-gDLegD7wnoA_gE9QMAAABE9QMAAgAA&num=3&sig=AGiWqtzwl0AY94_WS2-miKs-b0_Koa0muw&client=ca-pub-1607124478120364&adurl=http://www.healthtech.com/imt>-
> > www.healthtech.com/imt<http://googleads.g.doubleclick.net/aclk?sa=l&ai=BTv1YZow3TMjfF4jSjQTH-a30A-zVgLMB_O6n4BPAjbcB0PAzEAMYAyCz3PoBKAQ4AFCn39XgBmDJjvCGyKOgGbIBDnd3dy5naXptYWcuY29tugEKMzAweDI1MF9qc8gBAdoBpQFodHRwOi8vd3d3Lmdpem1hZy5jb20vYW50aWJvZGllcy1uZXV0cmFsaXplLW92ZXItOTAtcGVyY2VudC1vZi1oaXYtc3RyYWlucy8xNTY2Mi8_dXRtX3NvdXJjZT1HaXptYWcrU3Vic2NyaWJlcnMmdXRtX2NhbXBhaWduPTkxOTI2OTU0YWQtVUEtMjIzNTM2MC00JnV0bV9tZWRpdW09ZW1haWyAAgGoAwHoA_EE6AO4A-gDLegD7wnoA_gE9QMAAABE9QMAAgAA&num=3&sig=AGiWqtzwl0AY94_WS2-miKs-b0_Koa0muw&client=ca-pub-1607124478120364&adurl=http://www.healthtech.com/imt>
> > 4 Conferences, ONE Location! Strategies for Tomorrow's Vaccine
> > Monoclonal 
> > Antibodies<http://googleads.g.doubleclick.net/aclk?sa=l&ai=BYqSHZow3TMjfF4jSjQTH-a30A4D5gH2K_u6uDcCNtwGwzV4QBBgEILPc-gEoBDgAUKab5eUFYMmO8IbIo6AZsgEOd3d3Lmdpem1hZy5jb226AQozMDB4MjUwX2pzyAEB2gGlAWh0dHA6Ly93d3cuZ2l6bWFnLmNvbS9hbnRpYm9kaWVzLW5ldXRyYWxpemUtb3Zlci05MC1wZXJjZW50LW9mLWhpdi1zdHJhaW5zLzE1NjYyLz91dG1fc291cmNlPUdpem1hZytTdWJzY3JpYmVycyZ1dG1fY2FtcGFpZ249OTE5MjY5NTRhZC1VQS0yMjM1MzYwLTQmdXRtX21lZGl1bT1lbWFpbIACAagDAegD8QToA7gD6AMt6APvCegD-AT1AwAAAET1AwACAAA&num=4&sig=AGiWqtw7RHMxVvMY784iGjNUp_kENoQulA&client=ca-pub-1607124478120364&adurl=http://antibodies.sdix.com/product/monoclonal/>-
> > antibodies.SDIX.com<http://googleads.g.doubleclick.net/aclk?sa=l&ai=BYqSHZow3TMjfF4jSjQTH-a30A4D5gH2K_u6uDcCNtwGwzV4QBBgEILPc-gEoBDgAUKab5eUFYMmO8IbIo6AZsgEOd3d3Lmdpem1hZy5jb226AQozMDB4MjUwX2pzyAEB2gGlAWh0dHA6Ly93d3cuZ2l6bWFnLmNvbS9hbnRpYm9kaWVzLW5ldXRyYWxpemUtb3Zlci05MC1wZXJjZW50LW9mLWhpdi1zdHJhaW5zLzE1NjYyLz91dG1fc291cmNlPUdpem1hZytTdWJzY3JpYmVycyZ1dG1fY2FtcGFpZ249OTE5MjY5NTRhZC1VQS0yMjM1MzYwLTQmdXRtX21lZGl1bT1lbWFpbIACAagDAegD8QToA7gD6AMt6APvCegD-AT1AwAAAET1AwACAAA&num=4&sig=AGiWqtw7RHMxVvMY784iGjNUp_kENoQulA&client=ca-pub-1607124478120364&adurl=http://antibodies.sdix.com/product/monoclonal/>
> > Custom mAb Designed, Developed and Produced by the Antibody Experts
> > Ads by 
> > Google<http://www.google.com/url?ct=abg&q=https://www.google.com/adsense/support/bin/request.py%3Fcontact%3Dabg_afc%26url%3Dhttp://www.gizmag.com/antibodies-neutralize-over-90-percent-of-hiv-strains/15662/%253Futm_source%253DGizmag%252BSubscribers%2526utm_campaign%253D91926954ad-UA-2235360-4%2526utm_medium%253Demail%26hl%3Den%26client%3Dca-pub-1607124478120364%26adU%3Dwww.HIVTreatmentIsPower.com%26adT%3DFind%2Ban%2BASO%2BNear%2BYou%26adU%3Dwww.promab.com%26adT%3DCustom%2BAntibodies%26adU%3Dwww.healthtech.com/imt%26adT%3DVaccine%2BSummit%2B2010%26adU%3Dantibodies.SDIX.com%26adT%3DMonoclonal%2BAntibodies%26gl%3DUS&usg=AFQjCNFrAxCPoxlTzuK5p_cWbHqAWyJx5A>
> >
> > Research efforts to find individual antibodies that can neutralize HIV
> > strains have been difficult because the virus continuously changes its
> > surface proteins to evade recognition by the immune system. As a consequence
> > of these changes, an enormous number of HIV variants exist worldwide.
> > However, there are a few surface areas that remain nearly constant across
> > all variants of HIV and scientists have now discovered two potent human
> > antibodies that attach to one of these sites and can stop more than 90
> > percent of known global HIV strains from infecting human cells in the
> > laboratory.
> >
> > Led by a team from the National Institute of Allergy and Infectious
> > Diseases<http://www.niaid.nih.gov/>(NIAID) Vaccine Research Center
> > (VRC), the scientists found two naturally
> > occurring, powerful antibodies called VRC01 and VRC02 in an HIV infected
> > individual's blood using a novel molecular device they developed that hones
> > in on the specific cells that make antibodies against HIV. The device is an
> > HIV protein that the scientists modified so it would react only with
> > antibodies specific to the site where the virus binds to cells it infects.
> >
> > The scientists found that VRC01 and VRC02 neutralize more HIV strains with
> > greater overall strength than previously known antibodies to the virus.
> > According to the scientists, these antibodies could be used to design
> > improved HIV vaccines, or could be further developed to prevent or treat HIV
> > infection. The method used to find these antibodies could be applied to
> > isolate therapeutic antibodies for other infectious diseases as well.
> >
> > The researchers also determined the atomic-level structure of VRC01 when it
> > is attaching to HIV. This has enabled the team to define how the antibody
> > works and to precisely locate where it attaches to the virus. With this
> > knowledge, they have begun to design components of a candidate vaccine that
> > could teach the human immune system to make antibodies similar to VRC01 that
> > might prevent infection by the vast majority of HIV strains worldwide.
> >
> > One of the few identified areas on the HIV’s surface that remains constant
> > across all variants is called CD4 binding site. It is located on the surface
> > spikes used by HIV to attach to immune system cells and infect them. The
> > VRC01 and VRC02 antibodies found by the scientists block HIV infection by
> > attaching to the CD4 binding site, preventing the virus from latching onto
> > immune cells.
> >
> > “The antibodies attach to a virtually unchanging part of the virus, and 
> > this
> > explains why they can neutralize such an extraordinary range of HIV
> > strains,† says Dr. Mascola, the deputy director of the VRC.
> >
> > With these antibodies in hand, a team led by Dr. Kwong, chief of the
> > structural biology section at the VRC, determined the atomic-level molecular
> > structure of VRC01 when attached to the CD4 binding site. They then examined
> > this structure in light of natural antibody development to ascertain the
> > steps that would be needed to elicit a VRC01-like antibody through
> > vaccination.
> >
> > Antibody development begins with the mixing of genes into new combinations
> > within the immune cells that make antibodies. Examination of the structure
> > of VRC01 attached to HIV suggested that, from a genetic standpoint, the
> > immune system likely could produce VRC01 precursors readily. The researchers
> > also confirmed that VRC01 does not bind to human cells â€" a characteristic
> > that might otherwise lead to its elimination during immune development, a
> > natural mechanism the body employs to prevent autoimmune disease.
> >
> > In the final stage of antibody development, antibody-producing B cells
> > recognize specific parts of a pathogen and then mutate, or mature, so the
> > antibody can bind to the pathogen more firmly. VRC01 precursors do not bind
> > tightly to HIV, but rather mature extensively into more powerfully
> > neutralizing forms. This extensive antibody maturation presents a challenge
> > for vaccine design. In their paper, Dr. Kwong and colleagues explore how
> > this challenge might be addressed by designing vaccine components that could
> > guide the immune system through this stepwise maturation process and
> > facilitate the generation of a VRC01-like antibody from its precursors. The
> > scientists currently are performing research to identify these components.
> >
> > “The discoveries we have made may overcome the limitations that have long
> > stymied antibody-based HIV vaccine design,† says Dr. Kwong.
> >
> > A pair of articles about these findings appear in the online edition of *
> > Science <http://www.sciencemag.org/>*.
> >
> >
> > --
> > Celebrating 10 years of bringing diversity to perversity!
> > Mahogany at: http://groups.yahoo.com/group/mahogany_pleasures_of_darkness/
> >
> 
> 
> 
> 
> ------------------------------------
> 
> Post your SciFiNoir Profile at
> http://groups.yahoo.com/group/scifinoir2/app/peoplemap2/entry/add?fmvn=mapYahoo!
>  Groups Links
> 
> 
> 
> 
> 
> 
> -- 
> Celebrating 10 years of bringing diversity to perversity! 
> Mahogany at: http://groups.yahoo.com/group/mahogany_pleasures_of_darkness/
> 

Reply via email to